Moneycontrol PRO

business

Tough to raise funds; buy pharma, FMCG: ChrysCapital

At Chyrscapital they like companies with large presence in domestic pharma market. They like IPCA Labs because it is a stable growth story and expect a sustainable growth of 18-20 percent growth for the long-term.

first published: Jun 6, 2013 02:10 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347